|
|
|
1
|
|
Ms Dianne Gorman - Senator Henderson - question on notice from the public hearing on 13 November 2020 (received 16 November 2020)
|
2
|
|
Dr Michelle Jongenelis - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 19 November 2020)
|
3
|
|
Dr Coral Gartner - Senator Sheldon - Prescription of nicotine in e-cigarettes - written question on notice QoN008-01 - 18 November 2020 (received 19 November 2020)
|
4
|
|
Dr Coral Gartner - Senator Sheldon - Treatment of nicotine for e-cigarettes - written question on notice QoN008-02 - 18 November 2020 (received 19 November 2020)
|
5
|
|
Dr Coral Gartner - Senator Sheldon - Taxation treatment for e-cigarettes - written question on notice QoN008-03 - 18 November 2020 (received 19 November 2020)
|
6
|
|
Dr Coral Gartner - Senator Sheldon - The likely effect of applying the same taxation treatment or any additional taxes on e-cigarettes - written question on notice QoN008-04 - 18 November 2020 (received 19 November 2020)
|
7
|
|
Mr Christopher Snowdon - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 20 November 2020)
|
8
|
|
Professor John Britton - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 20 November 2020)
|
9
|
|
Professor Peter Hajek - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 20 November 2020)
|
10
|
|
Professor Chris Bullen - Senator Sheldon - Increase in the use of e-cigarettes - written question on notice QoN002-01 - 18 November 2020 (received 20 November 2020)
|
11
|
|
Professor Chris Bullen - Senator Sheldon - Regulation of nicotine - written question on notice QoN002-02 - 18 November 2020 (received 20 November 2020)
|
12
|
|
Professor Chris Bullen - Senator Sheldon - Regulation on nicotine through the Therapeutic Goods Administration - written question on notice QoN002-03 - 18 November 2020 (received 20 November 2020)
|
13
|
|
Professor Chris Bullen - Senator Sheldon - Regulation on nicotine through the Australian Competition & Consumer Commission - written question on notice QoN002-04 - 18 November 2020 (received 20 November 2020)
|
14
|
|
Professor Kenneth E. Warner, PhD - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 20 November 2020)
|
15
|
|
Australian Tobacco Harm Reduction Association - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 20 November 2020)
|
16
|
|
Professor Wayne Hall PhD AM FASSA FHMS - public hearing on 13 November 2020 (received on 20 November 2020)
|
17
|
|
Australian Council on Smoking and Health - Senator Hughes - written questions on notice QoN013-01-QoN013-02 - 19 November 2020 (received 20 November 2020)
|
18
|
|
CAPHRA - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 20 November 2020)
|
19
|
|
Professor Coral Gartner - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 20 November 2020)
|
20
|
|
Dr David Mutch - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 20 November 2020)
|
21
|
|
Professor Emily Banks - Senator Hughes - Additional evidence on continuing regular smoking in relation to e-cigarette use - public hearing on 13 November 2020 (received on 20 November 2020)
|
22
|
|
Professor Emily Banks - Senator Sheldon - Evidence on smoking in young people in Australia - public hearing on 13 November 2020 (received on 20 November 2020)
|
23
|
|
Professor Emily Banks - Senator Hughes - Eligibility criteria, consideration of nicotine dose and exclusion of data from specific study - public hearing on 13 November 2020 (received on 20 November 2020)
|
24
|
|
Professor Emily Banks - Senator Siewert - Evidence on why young people move from e-cigarettes to smoking - public hearing on 13 November 2020 (received on 20 November 2020)
|
25
|
|
Professor Emily Banks - Senator Henderson - Evidence on the likely impact on smoking prevalence in Australia of increased smoking in young people resulting from use of e-cigarettes - public hearing on 13 November 2020 (received on 20 November 2020)
|
26
|
|
Dr Michelle Jongenelis - Senator Hughes - written questions on notice QoN013-01-QoN013-02 - 19 November 2020 (received 20 November 2020)
|
27
|
|
Professor Ron Borland - Senator Sheldon - View about the tax treatment of nicotine for e-cigarettes - written question on notice QoN007-01 - 19 November 2020 (received 21 November 2020)
|
28
|
|
Professor Ron Borland - Senator Sheldon - Taxation treatment for e-cigarettes - written question on notice QoN007-02 - 19 November 2020 (received 21 November 2020)
|
29
|
|
Professor Ron Borland - Senator Sheldon - The likely effect of applying the same taxation treatment or any additional taxes on e-cigarettes - written question on notice QoN007-03 - 19 November 2020 (received 21 November 2020)
|
30
|
|
Professor Robert Beaglehole - Senator Sheldon - written questions on notice QoN001-01-QoN001-04 - 18 November 2020 (received 22 November 2020)
|
31
|
|
Professor Michelle Jongenelis - Senator Griff - Statements made by Adjunct Professor John Skerritt of the Therapeutic Goods Administration - written question on notice QoN016-01 - 20 November 2020 (received 22 November 2020)
|
32
|
|
Australian Council on Smoking and Health - Senator Hughes - written questions on notice QoN013-01-QoN013-02 - 19 November 2020 (received 23 November 2020)
|
33
|
|
Australian Council on Smoking and Health - Senator Griff - Statements made by Adjunct Professor John Skerritt of the Therapeutic Goods Administration - written question on notice QoN016-01 - 20 November 2020 (received 23 November 2020)
|
34
|
|
National Retail Association - Senator Sheldon - written questions on notice QoN004-01 - QoN004-19 - 18 November 2020 (received 23 November 2020)
|
35
|
|
Thoracic Society of Australia - Senator Hughes - Evidence on vaping being less harmful than tobacco smoking - written question on notice QoN013-01 - 19 November 2020 (received 24 November 2020)
|
36
|
|
Thoracic Society of Australia - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN013-02 - 19 November 2020 (received 24 November 2020)
|
37
|
|
Professor Emily Banks - Senator Canavan - Evidence on e-cigarette use in never smokers - public hearing on 13 November 2020 (received on 24 November 2020)
|
38
|
|
Professor Ron Borland - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 24 November 2020)
|
39
|
|
Professor David Sweanor - written questions on notice QoN01-QoN08 - 19 November 2020 (received 24 November 2020)
|
40
|
|
National Drug and Alcohol Research Centre - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 25 November 2020)
|
41
|
|
Professor Emily Banks - Senator Griff - Statements made by Adjunct Professor John Skerritt of the Therapeutic Goods Administration QoN016-01 - 20 November 2020 (received 25 November 2020)
|
42
|
|
Professor Wayne Hall - Senator Sheldon - written questions on notice QoN01-QoN08 - 18 November 2020 (received 25 November 2020)
|
43
|
|
Professor Simon Chapman - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 25 November 2020)
|
44
|
|
Vapoureyes - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 25 November 2020)
|
45
|
|
Professor Wayne Hall - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 25 November 2020)
|
46
|
|
Mr James Reid - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 25 November 2020)
|
47
|
|
Professor Chris Bullen & Associate Professor Natalie Walker - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 25 November 2020)
|
48
|
|
Dr Alex Wodak AM - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 25 November 2020)
|
49
|
|
TSG Lloyds & TSG Claremont Plaza - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 25 November 2020)
|
50
|
|
Professor Coral Gartner - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 25 November 2020)
|
51
|
|
The Royal Australian and New Zealand College of Psychiatrists - Senator Hughes - written questions on notice QoN013-01-QoN013-02 - 19 November 2020 (received 25 November 2020)
|
52
|
|
The Royal Australian College of General Practitioners - Senator Hughes - written questions on notice QoN013-01-QoN013-02 - 19 November 2020 (received 25 November 2020)
|
53
|
|
Factasia - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 25 November 2020)
|
54
|
|
Ms Dianne Gorman - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 25 November 2020)
|
55
|
|
Royal Australasian College of Physicians - Senator Hughes - Evidence on vaping being less harmful than tobacco smoking - written question on notice QoN013-01 - 19 November 2020 (received 25 November 2020)
|
56
|
|
Royal Australasian College of Physicians -Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN013-02 - 19 November 2020 (received 25 November 2020)
|
57
|
|
Australian Medical Association - Senator Hughes - written questions on notice QoN013-01-QoN013-02 - 19 November 2020 (received 25 November 2020)
|
58
|
|
National Retail Association - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 25 November 2020)
|
59
|
|
Emeritus Professor Mike Daube - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 25 November 2020)
|
60
|
|
Mr Clive Bates - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 25 November 2020)
|
61
|
|
Mr Clive Bates - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 25 November 2020)
|
62
|
|
Australian Tobacco Harm Reduction Association - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 26 November 2020)
|
63
|
|
Ms Hayley Dekker - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 26 November 2020)
|
64
|
|
Professor Hayden McRobbie - Senator Sheldon - Taxation treatment of nicotine for e-cigarettes - written question on notice QoN005-01 - 18 November 2020 (received 26 November 2020)
|
65
|
|
Professor Hayden McRobbie - Senator Sheldon - Taxation treatment for e-cigarettes - written question on notice QoN005-02 - 18 November 2020 (received 26 November 2020)
|
66
|
|
Professor Hayden McRobbie - Senator Sheldon - The likely effect of applying the same taxation treatment or any additional taxes on e-cigarettes - written question on notice QoN005-03 - 18 November 2020 (received 26 November 2020)
|
67
|
|
Professor Emily Banks - Senator Hughes - Evidence on delivery of nicotine - written questions on notice QoN019-01 - 25 November 2020 (received 30 November 2020)
|
68
|
|
Professor Emily Banks - Senator Hughes - Evidence on e-cigarettes for smoking cessation - written questions on notice QoN019-02 - 25 November 2020 (received 30 November 2020)
|
69
|
|
Professor Emily Banks - Senator Hughes - Evidence on e-cigarette use in never smokers - written questions on notice QoN019-03 - 25 November 2020 (received 30 November 2020)
|
70
|
|
Department of Health - Senator Canavan - Involvement of a health care professional in smoking cessation attempts - public hearing on 13 November 2020 (received on 30 November 2020)
|
71
|
|
Department of Health - Senator Canavan - Number of prescriptions for e-cigarettes - public hearing on 13 November 2020 (received on 30 November 2020)
|
72
|
|
Department of Health - Senator Henderson - Summary of the most recent research that identifies the harm of e-cigarettes - public hearing on 13 November 2020 (received on 30 November 2020)
|
73
|
|
Professor Emily Banks - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 1 December 2020)
|
74
|
|
AMPOL - public hearing on 13 November 2020 (received on 1 December 2020)
|
75
|
|
AMPOL - Senator Sheldon - written questions on notice QoN01-QoN08 - 19 November 2020 (received 1 December 2020)
|
76
|
|
AMPOL - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 1 December 2020)
|
77
|
|
AMPOL - Senator Sheldon - written questions on notice QoN003-1-QoN003-11 - 18 November 2020 (received 1 December 2020)
|
78
|
|
CSIRO - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 2 December 2020)
|
79
|
|
Emeritus Professor Mike Daube & Emeritus Professor Simon Chapman - Senator Griff - Harm reduction strategies - written question on notice QoN015-01 - 20 November 2020 (received 25 November 2020)
|
80
|
|
Emeritus Professor Mike Daube & Emeritus Professor Simon Chapman - Senator Griff - Views regarding vaping health claims - written question on notice QoN014-02 - 20 November 2020 (received 25 November 2020)
|
81
|
|
Emeritus Professor Mike Daube & Emeritus Professor Simon Chapman - Senator Griff - Risks from taking a more relaxed approach to vaping in Australia - written question on notice QoN014-04 - 20 November 2020 (received 25 November 2020)
|
82
|
|
Emeritus Professor Mike Daube & Emeritus Professor Simon Chapman - Senator Griff - Evidence on tobacco companies - written question on notice QoN015-05 - 20 November 2020 (received 25 November 2020)
|
83
|
|
Emeritus Professor Mike Daube & Emeritus Professor Simon Chapman - Senator Griff - Smoking rates - written question on notice QoN014-06 - 20 November 2020 (received 25 November 2020)
|
84
|
|
Emeritus Professor Mike Daube & Emeritus Professor Simon Chapman - Senator Griff - Statements made by Adjunct Professor John Skerritt of the Therapeutic Goods Administration - written question on notice QoN014-09 - 20 November 2020 (received 25 November 2020)
|
85
|
|
Emeritus Professor Mike Daube & Emeritus Professor Simon Chapman - Senator Griff - Overseas approaches to vaping - written question on notice QoN015-07 - 015-08 - 20 November 2020 (received 25 November 2020)
|
86
|
|
Australian Council on Smoking and Health - Senator Siewert - Speech by David Davies - public hearing on 19 November 2020 (received on 23 November 2020)
|
87
|
|
Professor Ron Borland - Senator Sheldon - Declaration in regard to any financial associations with the tobacco, vaping and nicotine industries - public hearing on 13 November 2020 (received 16 November 2020) and response from Professor Simon Chapman (received 9 December 2020)
|
88
|
|
Professor Ron Borland - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 4 December 2020)
|
89
|
|
Australian Border Force - Senator Hughes - Direct or indirect support received from the Pharmaceutical industry - written question on notice QoN020-01 - 25 November 2020 (received 7 December 2020)
|
90
|
|
New Zealand Ministry of Heath - Senator Hughes - written questions on notice QoN017-01-QoN017-04 - 23 November 2020 (received 9 December 2020) and response from Emeritus Professor Daube to QoN017-01 (received on 15 December 2020)
|